+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk of incident diabetes among patients treated with statins ezetimibe: Lessons from a lipid clinic after an 8-year follow-up

Risk of incident diabetes among patients treated with statins ezetimibe: Lessons from a lipid clinic after an 8-year follow-up

Atherosclerosis 241(1): E223-E224

(PDF emailed within 0-6 h: $19.90)

Accession: 064751065

Download citation: RISBibTeXText

DOI: 10.1016/j.atherosclerosis.2015.04.1046

Related references

Risk of incident diabetes among patients treated with statins: population based study. Bmj 346: F2610-F2610, 2013

A One-Year Follow-Up of Individuals with Diabetes at Very High Cv Risk Treated With Statins: Outcomes and Health Care Costs. Value in Health 18(7): A380, 2015

Statins and risk of treated incident diabetes in a primary care population. British Journal of Clinical Pharmacology 75(4): 1118-1124, 2013

The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis 24(7): 735-748, 2017

Comparison of lipid lowering effect of sibutramine in patients treated or not treated with statins--3 month follow-up. Prague Medical Report 108(4): 333-338, 2008

A One-Year Follow-Up of Patients with Acute Coronary Syndrome (Acs) and Diabetes Treated with Statins: Outcomes and Health Care Costs Supported by Italian National Health Service. Value in Health 18(7): A378-A379, 2015

Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk. Nutrition, Metabolism, and Cardiovascular Diseases 23(11): 1101-1106, 2014

Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran Lipid and Glucose Study. Diabetic Medicine 28(11): 1330-1336, 2012

Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic. Current Medical Research and Opinion 2016: 1-6, 2016

Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe. JAMA Network Open 1(8): E185554-E185554, 2019

Risk factors of incident type 2-diabetes mellitus over a 3-year follow-up: Results from a large Australian sample. Diabetes Research and Clinical Practice 108(2): 306-315, 2015

Statins and risk of incident diabetes. Lancet 375(9732): 2139; Author Reply 2141-2, 2010

Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN). European Journal of Medical Research 10(8): 339-344, 2005

Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes. Journal of Vascular Surgery 49(4): 1083-1084, 2009

THU0082Medication Impact on The Risk of Incident Diabetes Mellitus in Patients with Rheumatoid Arthritis: Hydroxychloroquine and Abatacept Protect while Glucocorticoids and Statins Worsen: Table 1. Annals of the Rheumatic Diseases 75(Suppl 2): 208.4-209, 2016